N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer promotes tumor-specific B cell responses via natural killer cell activation

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 955-961

  Hulikova, Katarina ^a   Svoboda, Jan ^a   Benson, Veronika ^a   Grobarova, Valeria ^a   Fiserova, Anna ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

ADCC reaction; Antibody formation; B16F10 melanoma; GN8P; IFN ; NK cells

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DENDRIMER; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MESSENGER RNA; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE COATED POLYAMIDOAMINE DENDRIMER; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; MELANOMA; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN MONONUCLEAR CELL; TUMOR IMMUNITY; UPREGULATION;

EID: 84860405064     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.02.009     Document Type: Article

References (38)

1. McGreal EP,Martinez-Pomares L,Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004;41(11):1109-21. (Pubitemid 39345392)
2. Garcia-Vallejo JJ, van Kooyk Y. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol Rev 2009;230(1):22-37.
3. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009;9(8):568-80.
4. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectinlike receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993;11:613-35. (Pubitemid 23115019)
5. Iizuka K, Naidenko O, Plougastel B, Fremont D, Yokoyama WM. Genetically-linked C-type lectin-related ligands for the NKR-P1 NK cell receptors. Nat Immunol 2003;4: 801-7. (Pubitemid 36986765)
6. Aust JG, Gays F, Mickiewicz KM, Buchanan E, Brooks CG. The expression and function of the NKRP1 receptor family in C57BL/6 mice. J Immunol 2009;183: 106-16.
7. Bezouska K, Kren V, Kieburg C, Lindhorst TK. GlcNAc-terminated glycodendrimers form defined precipitates with the soluble dimeric receptor of rat natural killer cells, sNKR-P1. FEBS Lett 1998;426:243-7. (Pubitemid 28198135)
8. Carlyle JR, Mesci A, Fine JH, Chen P, Belanger S, Tai LH, et al. Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol 2008;20(6):321-30.
9. Fiserova A, Bezouska K, Svabova L, Jedelsky P, Pucova A, Luptovcova M, et al. Analysis of glycodendrimers effect(s) in tumor microenvironment. Immunol Lett 2003;87:206-10.
10. Pospisil M, Vannucci L, Fiserova A, Sadalapure K, Krausova K, Horvath O, et al. Glycodendrimeric ligands of C-type lectin receptors as therapeutic agents in experimental cancer. Adv Exp Med Biol 2001;495:343-8.
11. Vannucci L, Fiserova A, Sadalapure K, Lindhorst TK, Kuldova M, Rossmann P, et al. Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Int J Oncol 2003;23:285-96.
12. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5):503-10. (Pubitemid 351560519)
13. Amigorena S, Bonnerot C, Fridman WH, Teillaud JL. Recombinant interleukin-2- activated natural killer cells regulate IgG2a production. Eur J Immunol 1990;20: 1781-7. (Pubitemid 20290914)
14. Becker JC, Kolanus W, Lonnemann C, Schmidt RE. Human natural killer clones enhance in vitro antibody production by tumour necrosis factor alpha and gamma interferon. Scand J Immunol 1990;32(2):153-62. (Pubitemid 20235011)
15. Snapper CM, Hamaguchi H, Moorman MA, Sneed R, Smoot D, Mond JJ. Natural killer cells induce activated murine B cells to secrete Ig. J Immunol 1994;151: 5251-60.
16. Wilder JA, Koh CY, Yuan D. The role of NK cells during in vivo antigen-specific antibody response. J Immunol 1996;156:146-52. (Pubitemid 26006957)
17. Koh CY, Yuan D. The effect of NK cell activation by tumor cells on antigen-specific antibody responses. J Immunol 1997;159:4745-52. (Pubitemid 127471009)
18. Blanca IR, Bere EW, Young HA, Ortaldo JR. Human B cell activation by autologous NK cells is regulated by CD40-CD40L ligand interaction: role of memory B cells and CD5+ B cells. J Immunol 2001;167:6132-9. (Pubitemid 33081539)
19. De Arruda Hinds LB, Alexandre-Moreira MS, Decote-Ricardo D, Nunes MP, Peçantha MT. Increased immunoglobulin secretion by B lymphocytes from Trypanosoma cruzi infected mice after B lymhocytes-natural killer cell interaction. Parasite Immunol 2001;23:581-6. (Pubitemid 34205868)
20. Yuan D. Interactions between NK cells and B lymphocytes. Adv Immunol 2004;84: 1-37.
21. Gao N, Dang T, Dunnick WA, Collins JT, Blaazar BR, Yuan D. Receptors and counterreceptors involved in NK-B cell interactions. J Immunol 2005;174:4113-9. (Pubitemid 40395988)
22. Hulikova K, Benson V, Svoboda J, Sima P, Fiserova A. N-acetyl-D- glucosaminecoated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation. Int Immunopharmacol 2009;9:792-9.
23. Snapper CM, Marcu KB, Zelazowski P. The immunoglobulin class switch: beyond "accessibility". Immunity 1997;6:217-23. (Pubitemid 27148588)
24. Lindhorst TK, Kieburg C. Glycocoating of oligovalent amines. Synthesis of thiourea-bridged cluster glycosides from glycosyl isothiocyanates. Agnew Chem 1996;108:2083-6.
25. Ullmannova V, Popescu NC. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev 2007;31(2):110-8. (Pubitemid 46669816)
26. Fiserova A, Starec M, Kuldova M, Kovaru H, Pav M, Vannucci L, et al. Effects of D2- dopamine and ?-adrenoreceptor antagonists in stress induced changes on immune responsiveness of mice. J Neuroimmunol 2002;130:55-65. (Pubitemid 35239993)
27. Koh CY, Yuan D. The functional relevance of NK cell-mediated upregulation of antigen-specific IgG2a responses. Cell Immunol 2000;204:135-42.
28. Nimmerjahn F, Ravetch JV. Antibodies, Fc receptors and cancer. Curr Opin Immunol 2007;19:239-45. (Pubitemid 46356962)
29. Sabbatini P, Kudryashov V, Ragupathi G, Danishefsky SJ, Livingston PO, Bornmann W, et al. Immunization of ovarian patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial. Int J Cancer 2000;87(1):79-85. (Pubitemid 30368419)
30. Slovin SF, Ragupathi G, Musselli C, Fernandez C, Diani M, Verbel D, et al. Thomsen- Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer. Cancer Immunol Immunother 2005;54(7):694-702. (Pubitemid 40884166)
31. Gilewski TA, Ragupathi G, Dickler M, Powell S, Bhuta S, Panageas K, et al. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clin Cancer Res 2007;13:2977-85. (Pubitemid 46849573)
32. Johansson M, DeNardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev 2008;222:145-54. (Pubitemid 351430362)
33. Hulikova K, Grobarova V, Krivohlava R, Fiserova A. Antitumor activity of N-acetyl- D-glucosamine-substituted glycoconjugates and combined therapy with keyhole limpet hemocyanin in B16F10 mouse melanoma model. Folia Microbiol Praha 2010;55(5):528-32.
34. Karlhofer FM, Yokoyama WM. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J Immunol 1991;146:3662-73.
35. Arase H, Arase N, Saito T. Interferon γ production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med 1996;183:2391-6. (Pubitemid 26158933)
36. MichelML,Mendes-da-CruzD, Keller AC, LochnerM, Schneider E, Dy M, et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci USA 2008;105(50):19845- 50.
37. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006;6(11):836-48. (Pubitemid 44631652)
38. Nishikawa H, Kato T, Tawara I, Ikeda H, Kuribayashi K, Allen PM, et al. IFN-γ controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. J Immunol 2005;175:4433-40. (Pubitemid 41361979)